Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.

PURPOSE To evaluate the long-term outcomes of radiofrequency ablation (RFA) as a first-line therapy for early-stage hepatocellular carcinoma (HCC) and determine the prognostic factors for survival. MATERIALS AND METHODS The institutional review board approved this retrospective study. From January 2006 to December 2007, 162 consecutive patients with cirrhosis (Child-Pugh class A and B, 137 and 25 patients, respectively) who underwent RFA as a first-line treatment for up to three HCCs with a maximum diameter of 5 cm (182 HCCs; mean diameter ± standard deviation, 2.59 cm ± 0.79; 17 multinodular forms) were included. After a mean follow-up of 50.3 months ± 19.9, results were analyzed for tumor recurrence, as well as overall and recurrence-free survival time. The Kaplan-Meier method and Cox proportional hazards regression model were used to evaluate the prognostic factors. RESULTS The cumulative incidence of local tumor progression (LTP) was 14.5% at 5 years, with tumor size as the only significant predictive factor (relative risk = 2.13, P = .007). Overall 5-year survival and recurrence-free survival rates were 67.9% and 25.9%, respectively. Significant predictive factors for poor overall survival were Child-Pugh class B (relative risk = 2.43, P = .011), serum α-fetoprotein level (relative risk per 100 units = 1.01; P < .001), and presence of portosystemic collaterals (relative risk = 2.15, P = .025). The development of LTP significantly shortened median recurrence-free survival (28.0 months without LTP vs 12.0 months with LTP) and necessitated a higher number of interventional procedures (2.2 sessions without LTP vs 5.1 sessions with LTP). CONCLUSION RFA is a safe and effective first-line treatment for early-stage HCC, with a 5-year survival rate of 67.9%. High serum α-fetoprotein level, advanced Child-Pugh class, and presence of portosystemic collateral vessels had a significant negative effect on overall survival.

[1]  Jae Young Lee,et al.  Percutaneous Radiofrequency Ablation with Multiple Electrodes for Medium-Sized Hepatocellular Carcinomas , 2011, Korean journal of radiology.

[2]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[3]  Y. Sakamoto,et al.  A long‐term follow‐up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy , 2005, Cancer.

[4]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[5]  S Nahum Goldberg,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria. , 2005, Radiology.

[6]  L. Ellis,et al.  Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis , 2005, Annals of Surgical Oncology.

[7]  K. Eguchi,et al.  Lens culinaris agglutinin-reactive α-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma , 2007, Journal of Gastroenterology.

[8]  Ming-de Lu,et al.  Long-Term Outcome of Percutaneous Ablation in Very Early-Stage Hepatocellular Carcinoma , 2011, Journal of Gastrointestinal Surgery.

[9]  Kyung-Suk Suh,et al.  Changes of portosystemic collaterals and splenic volume on CT after liver transplantation and factors influencing those changes. , 2008, AJR. American journal of roentgenology.

[10]  E. Vicaut,et al.  Radiofrequency ablation of hepatocellular carcinoma: Long‐term results and prognostic factors in 235 Western patients with cirrhosis , 2009, Hepatology.

[11]  A. Ruzzenente,et al.  Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. , 2003, Hepato-gastroenterology.

[12]  L. Mariani,et al.  Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.

[13]  M. Choi,et al.  Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series , 2007, European Radiology.

[14]  B. Kim,et al.  Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis. , 2009, Transplantation proceedings.

[15]  H-X Xu,et al.  Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients. , 2005, Clinical radiology.

[16]  J. Bruix,et al.  Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.

[17]  Katsunori Saigenji,et al.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. , 2007, AJR. American journal of roentgenology.

[18]  S. Todo,et al.  Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization , 2009, Annals of Surgical Oncology.

[19]  A. Muratore,et al.  Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival--a European single center experience. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  Y. Jeong,et al.  Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  M. Makuuchi,et al.  One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.

[22]  Carlo Bartolozzi,et al.  Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. , 2005, Radiology.

[23]  S. Fan,et al.  Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma , 2007, Journal of Gastrointestinal Surgery.

[24]  Sheung Tat Fan,et al.  Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. , 2008, Journal of the American College of Surgeons.

[25]  M. Di Stasi,et al.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results , 2001, European Radiology.

[26]  G. Giannelli,et al.  Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? , 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[27]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[28]  F. Giuliante,et al.  Liver resections for hepatocellular carcinoma in chronic liver disease: experience in an Italian centre. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  J. H. Lim,et al.  Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. , 2004, Radiology.

[30]  A. Ruzzenente,et al.  Radio Frequency Ablation for Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Factors for Survival , 2007, Journal of Gastrointestinal Surgery.

[31]  R. Wachsberg,et al.  Varices in portal hypertension: evaluation with CT. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[32]  Donald L. Miller,et al.  Society of Interventional Radiology clinical practice guidelines. , 2009, Journal of vascular and interventional radiology : JVIR.

[33]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[34]  J. Bruix,et al.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. , 1996, Gastroenterology.

[35]  Xiao-yan Xie,et al.  [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. , 2006, Zhonghua yi xue za zhi.

[36]  M. Makuuchi,et al.  Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. , 2007, Japanese journal of clinical oncology.

[37]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[38]  Adrian Fisher,et al.  Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. , 2003, Journal of the American College of Surgeons.

[39]  S. Iyer,et al.  Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma , 2009, Annals of Surgical Oncology.

[40]  Ryosuke Tateishi,et al.  nature publishing group ORIGINAL CONTRIBUTIONS 569 CME Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors LIVER , 2022 .

[41]  M. Mihara,et al.  Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. , 2000, Journal of the American College of Surgeons.

[42]  M. Kudo,et al.  Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation , 2007, Digestive Diseases.

[43]  T. Eberlein.  Trends in Morbidity and Mortality after Hepatic Resection for Hepatocellular Carcinoma: An Institute's Experience with 625 Patients , 2008 .

[44]  M. Choi,et al.  Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. , 2013, Journal of hepatology.

[45]  V. Mazzaferro.  Results of liver transplantation: With or without milan criteria? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.